ALL |
META-ANALYSIS |
CITATIONS |
|
Benefit-Cost Summary Statistics Per Participant | ||||||
---|---|---|---|---|---|---|
Benefits to: | ||||||
Taxpayers | $2,611 | Benefits minus costs | $5,769 | |||
Participants | $5,286 | Benefit to cost ratio | $4.16 | |||
Others | $372 | Chance the program will produce | ||||
Indirect | ($674) | benefits greater than the costs | 69% | |||
Total benefits | $7,595 | |||||
Net program cost | ($1,826) | |||||
Benefits minus cost | $5,769 | |||||
Meta-Analysis of Program Effects | ||||||||||||
Outcomes measured | Treatment age | No. of effect sizes | Treatment N | Effect sizes (ES) and standard errors (SE) used in the benefit-cost analysis | Unadjusted effect size (random effects model) | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
First time ES is estimated | Second time ES is estimated | |||||||||||
ES | SE | Age | ES | SE | Age | ES | p-value | |||||
Alcohol use disorder Clinical diagnosis of alcohol use disorder or symptoms measured on a validated scale. |
14 | 1 | 113 | -0.116 | 0.144 | 14 | -0.116 | 0.144 | 24 | -0.305 | 0.035 | |
Substance use^ Nonspecified substance use (i.e., alcohol, cannabis, or illicit drugs) that does not rise to the level of "disordered." |
14 | 1 | 109 | -0.093 | 0.149 | 16 | n/a | n/a | n/a | -0.246 | 0.100 | |
Alcohol use before end of high school Any use of alcohol by the end of high school, typically between ages 14 and 18. |
14 | 4 | 668 | -0.001 | 0.058 | 15 | -0.001 | 0.058 | 18 | 0.002 | 0.977 | |
Smoking before end of high school Any smoking of tobacco by the end of high school, typically between ages 14 and 18. |
14 | 2 | 179 | -0.045 | 0.108 | 14 | -0.045 | 0.108 | 18 | -0.113 | 0.288 | |
Cannabis use before end of high school Any use of cannabis by the end of high school, typically between ages 14 and 18. |
14 | 1 | 113 | -0.037 | 0.129 | 14 | -0.037 | 0.129 | 18 | -0.098 | 0.456 | |
Externalizing behavior symptoms Symptoms of externalizing behavior (e.g., aggressive, hostile, or disruptive behavior) measured on a validated scale. |
14 | 2 | 238 | -0.107 | 0.123 | 14 | -0.059 | 0.078 | 17 | -0.320 | 0.008 | |
Internalizing symptoms Symptoms of internalizing behavior (e.g., sadness, anxiety, or withdrawal) measured on a validated scale. |
14 | 2 | 222 | -0.079 | 0.103 | 15 | -0.079 | 0.103 | 18 | -0.207 | 0.090 | |
Suicide attempts^ An attempt to die by suicide resulting in survival. |
14 | 1 | 376 | -0.009 | 0.073 | 16 | n/a | n/a | n/a | -0.024 | 0.744 | |
Suicidal ideation^ Thinking about and/or planning death by suicide. |
14 | 1 | 376 | -0.042 | 0.073 | 16 | n/a | n/a | n/a | -0.111 | 0.131 | |
Initiation of sexual activity^ Self-reported sexual intercourse. |
14 | 2 | 192 | -0.065 | 0.145 | 14 | n/a | n/a | n/a | -0.173 | 0.237 | |
Illicit drug use before end of high school Any use of illicit drugs by the end of high school, typically between ages 14 to 18. When possible, we exclude cannabis/marijuana use disorder from this outcome. |
14 | 4 | 668 | -0.073 | 0.058 | 15 | -0.073 | 0.058 | 18 | -0.197 | 0.001 | |
Cannabis use disorder Clinical diagnosis of cannabis use disorder or symptoms measured on a validated scale. |
14 | 1 | 113 | -0.057 | 0.144 | 14 | -0.057 | 0.144 | 24 | -0.150 | 0.297 | |
STD risky behavior^ For youth, this outcome includes unprotected sex and other behaviors. For high-risk drug users, this also includes intravenous drug use. |
14 | 2 | 186 | -0.002 | 0.149 | 14 | n/a | n/a | n/a | -0.065 | 0.823 | Click to expand | Click to collapse |
Detailed Monetary Benefit Estimates Per Participant | ||||||
Affected outcome: | Resulting benefits:1 | Benefits accrue to: | ||||
---|---|---|---|---|---|---|
Taxpayers | Participants | Others2 | Indirect3 | Total |
||
Alcohol use disorder | Labor market earnings associated with alcohol abuse or dependence | $2,214 | $5,215 | $0 | $0 | $7,429 |
Property loss associated with alcohol abuse or dependence | $0 | $6 | $12 | $0 | $18 | |
Mortality associated with alcohol | $3 | $6 | $0 | $42 | $50 | |
Externalizing behavior symptoms | K-12 special education | $127 | $0 | $0 | $63 | $190 |
Health care associated with externalizing behavior symptoms | $209 | $59 | $216 | $104 | $588 | |
Internalizing symptoms | K-12 grade repetition | $3 | $0 | $0 | $2 | $5 |
Cannabis use before end of high school | Criminal justice system | $56 | $0 | $145 | $28 | $228 |
Program cost | Adjustment for deadweight cost of program | $0 | $0 | $0 | ($913) | ($913) |
Totals | $2,611 | $5,286 | $372 | ($674) | $7,595 | |
Detailed Annual Cost Estimates Per Participant | ||||
Annual cost | Year dollars | Summary | ||
---|---|---|---|---|
Program costs | $1,548 | 2018 | Present value of net program costs (in 2023 dollars) | ($1,826) |
Comparison costs | $0 | 2018 | Cost range (+ or -) | 20% |
Benefits Minus Costs |
Benefits by Perspective |
Taxpayer Benefits by Source of Value |
Benefits Minus Costs Over Time (Cumulative Discounted Dollars) |
The graph above illustrates the estimated cumulative net benefits per-participant for the first fifty years beyond the initial investment in the program. We present these cash flows in discounted dollars. If the dollars are negative (bars below $0 line), the cumulative benefits do not outweigh the cost of the program up to that point in time. The program breaks even when the dollars reach $0. At this point, the total benefits to participants, taxpayers, and others, are equal to the cost of the program. If the dollars are above $0, the benefits of the program exceed the initial investment. |
Estrada, Y., Rosen, A., Huang, S., Tapia, M., Sutton, M., Willis, L., . . . Prado, G. (2015). Efficacy of a brief intervention to reduce substance use and Human Immunodeficiency Virus infection risk among Latino youth. Journal of Adolescent Health, 57(6), 651-657.
Estrada, Y., Lee, T.K., Huang, S., Tapia, M.I., Velázquez, M.R., Martinez, M.J., . . . Prado, G. (2017). Parent-centered prevention of risky behaviors among Hispanic youths in Florida. American Journal of Public Health, 107(4), 607-613.
Estrada, Y., Lee, T. K., Wagstaff, R., M, R.L., Tapia, M.I., Velázquez, M.R., Sardinas, K., ... Prado, G. (2019). eHealth Familias Unidas: Efficacy trial of an evidence-based intervention adapted for use on the Internet with Hispanic families. Prevention Science : the Official Journal of the Society for Prevention Research, 20(1), 68-77.
Molleda, L., Estrada, Y., Lee, T.K., Poma, S., Bahamon, M., Tapia, M.I., . . . Tamayo, C.C. (2017). Short-term effects on family communication and adolescent conduct problems: Familias Unidas in Ecuador. Prevention Science, 18(7), 783-792.
Pantin, H., Prado, G., Lopez, B., Huang, S., Tapia, M.I., Schwartz, S.J., . . . Branchini, J. (2009). A randomized controlled trial of Familias Unidas for Hispanic adolescents with behavior problems. Psychosomatic Medicine, 71(9), 987-995.
Perrino, T., Pantin, H., Huang, S., Brincks, A., Brown, C.H., & Prado, G. (2016). Reducing the risk of internalizing symptoms among high‐risk Hispanic youth through a family intervention: A randomized controlled trial. Family Process, 55(1), 91-106.
Perrino, T., Brincks, A., Howe, G., Brown, C.H., Prado, G., & Pantin, H. (2016). Reducing internalizing symptoms among high-risk, Hispanic adolescents: Mediators of a preventive family intervention. Prevention Science, 17(5), 595-605.
Prado, G., Cordova, D., Huang, S., Estrada, Y., Rosen, A., Bacio, G.A., . . . McCollister, K. (2012). The efficacy of Familias Unidas on drug and alcohol outcomes for Hispanic delinquent youth: Main effects and interaction effects by parental stress and social support. Drug and Alcohol Dependence, 125.
Prado, G., Pantin, H., Huang, S., Cordova, D., Tapia, M.I., Velazquez, M.R., . . . Estrada, Y. (2012). Effects of a family intervention in reducing HIV risk behaviors among high-risk Hispanic adolescents: A randomized controlled trial. Archives of Pediatrics & Adolescent Medicine, 166(2), 127-33.
Vidot, D.C., Huang, S., Poma, S., Estrada, Y., Lee, T.K., & Prado, G. (2016). Familias Unidas’ crossover effects on suicidal behaviors among Hispanic adolescents: Results from an effectiveness trial. Suicide and Life-Threatening Behavior, 46.